
Opinion|Videos|April 2, 2024
Current Approaches to Treating Nonmetastatic CRPC
Author(s)Matthew Smith, MD, PhD, Brian Helfand, MD, PhD
Matthew Smith, MD, PhD, and Brian T. Helfand, MD, discuss the treatment of patients with nonmetastatic castration-resistant prostate cancer.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
High PHI scores are linked to increased odds of significant prostate cancer
2
Trial to evaluate novel combination in BCG-unresponsive NMIBC
3
Dosing begins in trial of alpha radioligand therapy for mCRPC
4
FDA grants fast track designation to Enolen for localized prostate cancer
5



















